Form 4: DuPont SVP & CIO Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


DuPont de Nemours, Inc.'s Senior Vice President and Chief Information Officer, Steven P. Larrabee, exercised stock options and subsequently sold a portion of his common stock holdings.

Summary

  • Steven P. Larrabee, SVP & CIO of DuPont de Nemours, Inc., executed transactions involving company stock on September 4 and 5, 2025.
  • On September 4, 2025, Larrabee exercised 25,000 stock options at an exercise price of $66.06 per share.
  • Immediately following the option exercise on September 4, 2025, he sold 25,000 shares of common stock at $76.50 per share.
  • On September 5, 2025, an additional 6,000 shares of common stock were sold at $78.00 per share.
  • These transactions were conducted under a Rule 10b5-1 pre-arranged trading plan.
  • Following these sales, Larrabee directly holds 42,585.1905 shares of common stock and indirectly holds 147.2117 shares in a Retirement Savings Plan.
  • He also retains 25,633 unexercised stock options, which became exercisable on December 31, 2021, and expire on August 5, 2029.

Sentiment

Score: 5

Explanation: Neutral. The filing reports routine insider transactions (option exercise and subsequent sales) under a 10b5-1 plan. While sales by an executive can sometimes be viewed negatively, the pre-planned nature and the fact that a significant number of options remain, along with direct and indirect shareholdings, suggest no strong positive or negative sentiment from this specific filing alone.

Positives

  • The transactions were executed under a Rule 10b5-1 plan, indicating pre-planned sales and potentially reducing concerns about opportunistic insider trading.
  • The exercise price of $66.06 was significantly lower than the sale prices of $76.50 and $78.00, indicating a profitable transaction for the insider.

Negatives

  • A senior executive selling a significant number of shares could be perceived negatively by the market, even if pre-planned.
  • The total sale of 31,000 shares represents a reduction in direct beneficial ownership by a key executive.

Risks

  • Potential negative market perception due to insider selling, which could put downward pressure on the stock price, despite the transactions being pre-planned under a Rule 10b5-1 plan.

Future Outlook

The filing indicates that the transactions were made pursuant to a Rule 10b5-1 plan, suggesting these sales were pre-scheduled and not necessarily indicative of a change in future outlook based on new, non-public information.

Management Comments

  • No direct quotes or paraphrased statements from management are included in this Form 4 filing, which primarily reports transaction details.

Industry Context

Insider sales, even when pre-planned, are routinely monitored by the market as they can sometimes signal management's perception of future company performance or valuation. For a diversified industrial company like DuPont, such transactions are typically viewed in the context of broader market conditions and the company's specific operational performance.

Comparison to Industry Standards

  • Insider transactions are common across all industries. The use of a Rule 10b5-1 plan aligns with best practices for executives to manage their equity holdings while mitigating insider trading concerns.
  • Comparable companies in the materials science or specialty chemicals sector, such as 3M (MMM) or Dow Inc. (DOW), also see executives utilize similar plans for equity diversification and liquidity.

Stakeholder Impact

  • Shareholders: May interpret the executive's sale of shares as a signal, though the Rule 10b5-1 plan mitigates concerns of opportunistic selling. The executive still retains significant holdings.
  • Employees: No direct impact from this filing.
  • Customers/Suppliers/Creditors: No direct impact from this filing.

Next Steps

  • No specific future actions or milestones are mentioned in this Form 4 filing beyond the reported transactions.

Key Dates

DateDescription
12/31/2021Date when all stock options became exercisable.
08/05/2029Expiration date of stock options.
09/04/2025Date of stock option exercise and initial common stock sale.
09/05/2025Date of subsequent common stock sale.
09/08/2025Filing date of the Form 4.

Recommendation

hold

This Form 4 filing details an executive's pre-planned sale of shares following an option exercise. While insider selling can sometimes be a bearish signal, the transactions were conducted under a Rule 10b5-1 plan, which suggests they are for personal financial planning rather than a reaction to new, negative company-specific information. The executive still retains a substantial number of shares and options. Therefore, this filing alone does not provide sufficient new information to warrant a change from a 'hold' position, as it's a routine executive compensation event rather than a fundamental shift in company prospects.

Keywords

DuPont, DD, Insider Trading, Form 4, Stock Options, Executive Compensation, Steven P. Larrabee, Share Sale, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.